Company: NYXH
Filing Date: 2025-03-20
Form Type: F-3
Source: 0001104659-25-026217
Chunk: 16

Company: Nyxoah SA
Filing Date: 2025-03-20
Form: F-3
Chunk 16
---
 in the United States is Nyxoah, Inc. Our agent for service of process in the United States is Corporation Service Company, 1090 Vermont Avenue N.W., Washington D.C. 20005.

#### Ordinary Shares
As of December 31, 2024, we had issued and outstanding 37,427,265 ordinary shares and as of March 19, 2025, we had issued and outstanding 37,427,265 ordinary shares. Each issued ordinary share is fully paid and has a par value of €0.1718 per ordinary share.

Holders of ordinary shares are entitled to one vote for each share held of record on all matters submitted to a vote of shareholders and do not have cumulative voting rights.

Any distribution made as result of winding-up, dissolution or liquidation of our company and any dividend declared will be distributed in proportion to the number of fully paid ordinary shares held.

#### History of Issued Share Capital
On February 10, 2022, we issued 25,000 ordinary shares pursuant to the exercise of warrants for an aggregate consideration of approximately €129,266.

On June 8, 2022, we issued 38,920 ordinary shares to our non-executive directors as part of their remuneration package for an aggregate consideration of approximately €6,686.

On September 30, 2022, we issued 10,000 ordinary shares pursuant to the exercise of warrants for an aggregate consideration of approximately €119,400.

On March 29, 2023, we issued 393,162 ordinary shares pursuant to an at-the-market program for aggregate consideration of approximately $2.8 million (approximately €2.5 million at the then-current exchange rates).

On March 30, 2023, we issued 2,047,544 ordinary shares pursuant to a private placement financing to historical Nyxoah shareholders, for an aggregate consideration of approximately €13.35 million (approximately $15.0 million at then-current exchange rates).

On April 17, 2023, we issued 375,000 ordinary shares pursuant to an at-the-market program for aggregate consideration of $3.0 million.

<div align='center'>12</div>

TABLE OF CONTENTS

On July 14, 2023, we issued 2,000 ordinary shares pursuant to the exercise of warrants for an aggregate consideration of approximately €10,840 (including share premium).

On August 29, 2023, we issued 10,000 ordinary shares pursuant to the